CFO
JNJ icon

CVA Family Office’s Johnson & Johnson JNJ Stock Holding History

CVA Family Office’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.47M Sell
9,737
-282
-3% -$65.7K 0.22% 69
2026
Q1 		$2.45M Buy
10,019
+934
+10% +$218K 0.26% 63
2025
Q4 		$1.88M Buy
9,085
+67
+0.7% +$13.2K 0.22% 64
2025
Q3 		$1.67M Buy
9,018
+429
+5% +$73.5K 0.22% 75
2025
Q2 		$1.31M Sell
8,589
-21
-0.2% -$3.23K 0.18% 85
2025
Q1 		$1.43M Buy
8,610
+2,296
+36% +$359K 0.22% 77
2024
Q4 		$913K Sell
6,314
-2,802
-31% -$434K 0.14% 95
2024
Q3 		$1.48M Buy
9,116
+2,459
+37% +$392K 0.24% 69
2024
Q2 		$973K Sell
6,657
-1,408
-17% -$209K 0.18% 85
2024
Q1 		$1.28M Buy
8,065
+27
+0.3% +$4.3K 0.23% 72
2023
Q4 		$1.26M Sell
8,038
-510
-6% -$78.2K 0.25% 69
2023
Q3 		$1.33M Buy
8,548
+1,040
+14% +$172K 0.3% 61
2023
Q2 		$1.24M Sell
7,508
-891
-11% -$144K 0.26% 65
2023
Q1 		$1.3M Buy
8,399
+715
+9% +$115K 0.29% 57
2022
Q4 		$1.36M Buy
7,684
+22
+0.3% +$3.8K 0.33% 55
2022
Q3 		$1.25M Buy
7,662
+590
+8% +$99.8K 0.34% 56
2022
Q2 		$1.25M Hold
7,072
– – 0.34% 53
2022
Q1 		$1.25M Buy
7,072
+2,290
+48% +$390K 0.3% 54
2021
Q4 		$818K Buy
4,782
+1,399
+41% +$229K 0.2% 76
2021
Q3 		$504K Sell
3,383
-2,677
-44% -$457K 0.36% 48
2021
Q2 		$998K Buy
6,060
+713
+13% +$118K 0.28% 55
2021
Q1 		$879K Buy
5,347
+2,396
+81% +$388K 0.33% 49
2020
Q4 		$464K Sell
2,951
-432
-13% -$63.8K 0.29% 57
2020
Q3 		$504K Buy
3,383
+180
+6% +$26.6K 0.36% 48
2020
Q2 		$450K Buy
3,203
+287
+10% +$41.8K 0.37% 45
2020
Q1 		$382K Buy
2,916
+373
+15% +$52.9K 0.39% 52
2019
Q4 		$371K Buy
+2,543
New +$345K 0.34% 52

Other funds holding JNJ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

CVA Family Office's JNJ Position: Q2 2026 in Review

CVA Family Office reduced its Johnson & Johnson (JNJ) stake by 2.8% in Q2 2026, selling an estimated $65.7K and leaving 9,737 shares worth $2.47M. The position accounts for 0.22% of the portfolio, ranked #69.

CVA Family Office first reported a position in JNJ in Q4 2019 and has held it in 27 quarters since. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • CVA Family Office held 9,737 shares of Johnson & Johnson worth $2.47M as of Q2 2026.
  • CVA Family Office sold 282 Johnson & Johnson shares in Q2 2026, an estimated $65.7K.
  • Johnson & Johnson made up 0.22% of CVA Family Office's portfolio in Q2 2026, its #69 holding.
  • CVA Family Office first reported a position in Johnson & Johnson in Q4 2019 and has held it in 27 quarters since.
  • 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on CVA Family Office's 13F filing for Q2 2026, filed 7 Aug 2026.